Drug Profile
Research programme: vaccines - Sinovac (Dalian) Vaccine Technology
Alternative Names: Measles virus vaccine - Sinovac Biotech/Dalian Vaccine Technology; Rubella virus vaccine - Sinovac Biotech/Dalian Vaccine TechnologyLatest Information Update: 28 May 2021
Price :
$50
*
At a glance
- Originator Sinovac (Dalian) Vaccine Technology
- Class Vaccines
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Rubella
Most Recent Events
- 28 May 2021 No recent reports of development identified for preclinical development in Rubella(Prevention) in China (Parenteral)
- 11 May 2019 Rubella vaccine is still in Preclinical trials in China
- 16 Jul 2016 No recent reports of development identified for preclinical development in Rubella(Prevention) in China (Parenteral)